The acquisition of Alfamation by inTEST Corporation is likely to have a positive short-term impact on INTT's stock price due to the expected accretive effect on earnings by 2025. Alfamation's significant annual revenue and backlog, coupled with its history of double-digit revenue growth, suggest a strong potential for enhancing inTEST's financial performance and market position. This strategic move aligns with inTEST's growth objectives within the Electronic Test division, potentially leading to increased investor confidence and stock valuation.